Evidence map›Paper›PMID 38317183›Full record

ArticleGenome medicine2024

Pro-inflammatory feedback loops define immune responses to pathogenic Lentivirus infection.

Aaron J Wilk, Joshua O Marceau, Samuel W Kazer, Ira Fleming, Vincent N Miao, Jennyfer Galvez-Reyes, Jason T Kimata, Alex K Shalek, Susan Holmes, Julie Overbaugh and 1 more

Abstract read
In one paragraph

Article in Genome medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Aaron J WilkStanford Immunology Program, Stanford University School of Medicine, Stanford, CA, 94305, USA.
Joshua O MarceauDivision of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, WA, 98109, USA.
Samuel W KazerInstitute for Medical Engineering & Science, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA.
Ira FlemingInstitute for Medical Engineering & Science, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA.
Vincent N MiaoInstitute for Medical Engineering & Science, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA.
Jennyfer Galvez-ReyesInstitute for Medical Engineering & Science, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA.
Jason T KimataDepartment of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, USA.
Alex K ShalekInstitute for Medical Engineering & Science, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA.
Susan HolmesDepartment of Statistics, Stanford University, Stanford, CA, 94305, USA.
Julie OverbaughDivision of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, WA, 98109, USA.
Catherine A BlishStanford Immunology Program, Stanford University School of Medicine, Stanford, CA, 94305, USA. cblish@stanford.edu.ORCID 0000-0001-6946-7627

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007365 · NIGMS · STANFORD UNIVERSITY · PI CHUA, KATRIN F · 1985 to 2021
$33.8M
Quantitative and functional characterization of therapeutic resistance in cancerU54CA217377 · NCI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI SHALEK, ALEX K · 2017 to 2021
$10.2M
Texas Developmental Center for AIDS ResearchP30AI161943 · NIAID · BAYLOR COLLEGE OF MEDICINE · PI RICE, ANDREW P · 2021 to 2025
$8.3M
Innate immune determinants of HIV rebound and persistenceR01HD103571 · NICHD · FRED HUTCHINSON CANCER RESEARCH CENTER · PI JULIE M. OVERBAUGH · 2020 to 2026
$6.7M
Defining the impact of drug use on immune function and fitness against HIV-1DP1DA053731 · NIDA · MASSACHUSETTS GENERAL HOSPITAL · PI SHALEK, ALEX K · 2021 to 2025
$5.9M
Gates Foundation INV-027498NCI NIH HHS 1U2CCA23319501NCI NIH HHS 1U54CA217377NCI NIH HHS U01 28020510NCI NIH HHS U54 CA217377NIAID NIH HHS P30 AI161943NICHD NIH HHS R01 HD103571NIDA NIH HHS 1DP1DA053731NIDA NIH HHS DP1 DA04508902NIDA NIH HHS DP1 DA053731NIGMS NIH HHS T32 GM007365NIH HHS T32 GM007365-44
6 · The paper itself

Abstract

backgroundThe Lentivirus human immunodeficiency virus (HIV) causes chronic inflammation and AIDS in humans, with variable rates of disease progression between individuals driven by both host and viral factors. Similarly, simian lentiviruses vary in their pathogenicity based on characteristics of both the host species and the virus strain, yet the immune underpinnings that drive differential Lentivirus pathogenicity remain incompletely understood.

methodsWe profile immune responses in a unique model of differential lentiviral pathogenicity where pig-tailed macaques are infected with highly genetically similar variants of SIV that differ in virulence. We apply longitudinal single-cell transcriptomics to this cohort, along with single-cell resolution cell-cell communication techniques, to understand the immune mechanisms underlying lentiviral pathogenicity.

resultsCompared to a minimally pathogenic lentiviral variant, infection with a highly pathogenic variant results in a more delayed, broad, and sustained activation of inflammatory pathways, including an extensive global interferon signature. Conversely, individual cells infected with highly pathogenic Lentivirus upregulated fewer interferon-stimulated genes at a lower magnitude, indicating that highly pathogenic Lentivirus has evolved to partially escape from interferon responses. Further, we identify CXCL10 and CXCL16 as important molecular drivers of inflammatory pathways specifically in response to highly pathogenic Lentivirus infection. Immune responses to highly pathogenic Lentivirus infection are characterized by amplifying regulatory circuits of pro-inflammatory cytokines with dense longitudinal connectivity.

conclusionsOur work presents a model of lentiviral pathogenicity where failures in early viral control mechanisms lead to delayed, sustained, and amplifying pro-inflammatory circuits, which in turn drives disease progression.

Indexed as

Lentivirus InfectionsSimian Acquired Immunodeficiency SyndromeSimian Immunodeficiency VirusAnimalsDisease ProgressionFeedbackHumansImmunityInterferonsInterferonsCell-cell communicationLentivirusesSingle-cell transcriptomics

Identifiers

PMID38317183
PMCPMC10840164

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.